EXCEL Trial (Evaluation of Xience Prime vs CABG for LM Disease)
{"Image DocumentName": "EXCEL Trial (Evaluation of Xience Prime vs CABG for LM Disease)", "Image ImageDescription": "LM disease (\u00b11,2,3 VD) and a SYNTAX score of \u2264 pazienti randomizzati. Xience Prime Stent. (ABBOTT Vascular) BPAC. End-point primario composito: morte, IM o stroke dopo un follow-up medio di 3 anni. Il principale end-point secondario \u2013 composito: Morte,IM, stroke o non prevista e ripetuta rivascolarizzazione. Tutti i paziernti saranno seguiti per 5 anni.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}